Table 2.
Average RSV-Associated Hospitalization Rates per 1000 Population per Age Group per Year
| Country | 0–2 mo (95% CI)a | 3–5 mo (95% CI)a | 6–11 mo (95% CI)a | 12–35 mo (95% CI)b | 36–59 mo (95% CI)b |
|---|---|---|---|---|---|
| EU-28c | 71.6 (66.6–76.6) | 38.9 (36–41.9) | 17.6 (16.1–19.1) | 5 (4.4–5.5) | 1 (0.9–1.1) |
| Austria | 65 (55.2–74.8) | 33.1 (27.7–38.5) | 13.5 (10.7–16.4) | 4.5 (3.5–5.5) | 0.9 (0.7–1.1) |
| Belgium | 68.6 (58.8–78.4) | 36.3 (30.9–41.7) | 15.9 (13.1–18.7) | 4.8 (3.8–5.9) | 1.2 (0.9–1.4) |
| Bulgaria | 81.8 (72–91.6) | 48.9 (43.5–54.3) | 21.2 (18.4–24) | 5.5 (4.5–6.6) | 1 (0.8–1.2) |
| Croatia | 79.4 (69.7–89.2) | 42.6 (37.2–48) | 19 (16.2–21.8) | 4.8 (3.8–5.8) | 0.9 (0.7–1.1) |
| Cyprus | 78.4 (68.6–88.2) | 41.3 (35.9–46.7) | 16.7 (13.9–19.5) | 5.5 (4.5–6.5) | 0.9 (0.7–1.1) |
| Czech Republic | 73.9 (64.1–83.7) | 41 (35.6–46.4) | 18.4 (15.6–21.2) | 5.7 (4.6–6.7) | 1.1 (0.9–1.3) |
| Denmark | 59.2 (49.3–69) | 40.7 (35.3–46.2) | 20.4 (17.5–23.2) | 7.5 (6.4–8.5) | 1.6 (1.4–1.8) |
| Estonia | 69.8 (60–79.7) | 37.3 (31.8–42.7) | 17.2 (14.4–20.1) | 5.1 (4–6.1) | 1 (0.8–1.2) |
| Finland | 77.8 (67.9–87.7) | 43.2 (37.7–48.6) | 16.6 (13.8–19.4) | 5.2 (4.2–6.3) | 0.8 (0.6–1) |
| France | 98.3 (88.5–108.1) | 48.8 (43.4–54.2) | 26 (23.2–28.8) | 5 (4–6.1) | 1.1 (0.9–1.3) |
| Germany | 72.5 (62.7–82.2) | 38.6 (33.2–44) | 17.5 (14.6–20.3) | 5.2 (4.2–6.3) | 1 (0.8–1.2) |
| Greece | 82.6 (72.8–92.4) | 44.3 (38.9–49.7) | 19.1 (16.3–21.9) | 4.5 (3.4–5.5) | 0.9 (0.7–1.1) |
| Hungary | 75.3 (65.5–85.1) | 44.7 (39.3–50.1) | 19.8 (16.9–22.6) | 5.4 (4.4–6.4) | 1.1 (0.9–1.3) |
| Ireland | 70.1 (60.3–79.9) | 47 (41.6–52.4) | 22.6 (19.8–25.4) | 7.1 (6–8.1) | 1.3 (1–1.5) |
| Italy | 80.9 (71.1–90.7) | 41.7 (36.3–47.1) | 18.1 (15.3–20.9) | 4.3 (3.2–5.3) | 0.9 (0.7–1.1) |
| Latvia | 75 (65.2–84.8) | 41.3 (35.9–46.7) | 18.4 (15.6–21.2) | 4.6 (3.6–5.7) | 1.1 (0.8–1.3) |
| Lithuania | 73.6 (63.8–83.4) | 38.5 (33.1–43.9) | 17 (14.2–19.8) | 4 (3–5) | 0.9 (0.7–1.1) |
| Luxembourg | 63.5 (53.7–73.3) | 32.6 (27.2–38) | 13.1 (10.3–15.9) | 5 (4–6.1) | 0.9 (0.7–1.1) |
| Malta | 64.8 (54.8–74.7) | 35.2 (29.7–40.7) | 17.9 (15–20.7) | 5.4 (4.4–6.5) | 1.3 (1.1–1.5) |
| Netherlands | 47.4 (37.6–57.3) | 19.9 (14.5–25.4) | 8.5 (5.7–11.3) | 1.9 (0.8–2.9) | 1.1 (0.9–1.3) |
| Norway | 54.6 (44.5–64.7) | 34.8 (29.3–40.3) | 15.4 (12.5–18.2) | 6.6 (5.6–7.7) | 0.5 (0.3–0.7) |
| Poland | 71.4 (61.6–81.2) | 36.5 (31.1–41.9) | 16.2 (13.4–19.1) | 4.6 (3.5–5.6) | 0.9 (0.7–1.1) |
| Portugal | 70.2 (60.4–80) | 31.7 (26.3–37.1) | 15.2 (12.4–18) | 4.5 (3.4–5.5) | 1.2 (0.9–1.4) |
| Romania | 68.8 (59–78.6) | 37.7 (32.3–43.1) | 19.4 (16.6–22.2) | 4.1 (3.1–5.2) | 1 (0.8–1.2) |
| Slovakia | 74.6 (64.8–84.3) | 42 (36.6–47.4) | 18.8 (16–21.6) | 4.7 (3.7–5.8) | 0.8 (0.6–1) |
| Slovenia | 75.4 (65.6–85.2) | 42.6 (37.2–48) | 17.6 (14.8–20.4) | 5.2 (4.2–6.2) | 1.1 (0.9–1.3) |
| Spain | 69.4 (59.6–79.2) | 32.6 (27.2–38) | 16.8 (14–19.6) | 3 (2–4.1) | 0.8 (0.6–1) |
| Sweden | 63 (53.1–72.8) | 35.5 (30.1–41) | 16.9 (14.1–19.7) | 5.3 (4.3–6.3) | 1.2 (1–1.4) |
| United Kingdom | 63.4 (47.8–79.1) | 38.9 (29.7–48.1) | 18.9 (14.2–23.6) | 6.1 (4.4–7.9) | 1.3 (1–1.6) |
Abbreviations: CI, confidence interval; EU, European Union; RSV, respiratory syncytial virus.
aRSV-associated hospitalization rates in these 3 age groups for the 29 countries are estimated by also including data from France reported by Demont and colleagues [15].
bRSV-associated hospitalization rates in these 2 age groups for the 29 countries are estimated by also including data from Spain reported by Gil-Prieto and colleagues [14].
cIncludes the United Kingdom and excludes Norway.